ESR1 and breast cancer: The reduced interaction between the super enhancer and ESR1 promoter locus in LATS1/2 deficient cells was further validated by multiplexed in-situ UMI-4C-seq in another ER+ breast cancer line T47D (Supplementary Fig. 5c–e).